Updates

Date: 4th September, 2026 The Manager, The Manager, Corporate Filings Department, Listing Compliance Department, BSE Limited, National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex, Bandra (E), Mumbai- 400 001. Mumbai - 400 051. Security Code: 532815 Symbol: SMSPHARMA Dear Sir/Madam, Sub: Intimation pursuant to Regulation 36(1)(b) of the SEBI (LODR) Regulations, 2015 – Dispatch of Letter with Web-Link and QR code to Annual Report Pursuant to Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that, the Company being dispatched a letter providing web-link including the exact path and QR code of the Integrated Annual Report for FY 2025-26 to the Shareholders whose e-mail addresses are not registered with the Company/ Registrar & Share Transfer Agent/ Depositories. A specimen copy of the letter is enclosed herewith for your records. This is being made available on the website of the Company www.smspharma.com Thanking you Yours faithfully For SMS Pharmaceuticals Limited Thirumalesh Tumma Company Secretary and Compliance Officer Encl: as above SPECIMEN SMS PHARMACEUTICALS LIMITED CIN: L24239TG1987PLC08066 Registered office: 8th Floor, Trendset Jayabheri Connect, Kondapur, Serilingampally, Ranga Reddy Dist., Hyderabad-500084, Telangana Phone. No: 040-6985 9999, Fax: 040-6985 9999 website: www.smspharma.com, email: cs@smspharma.com Date: 4th September 2026 Dear Shareholders, Sub: Web-link to Notice of 38th Annual General Meeting (AGM) of SMS Pharmaceuticals Limited (Company) and Integrated Annual Report for the Financial Year 2025-26: We are pleased to inform you that the 38th Annual General Meeting (AGM) of SMS Pharmaceuticals Limited (‘the Company’) is scheduled to be held on Tuesday, 29th September, 2026 at 10.30 A.M. (IST) through Video Conference (VC) / Other Audio-Visual Means (OAVM), in compliance with the various circulars issued by MCA and SEBI from time to time. The Notice of the 38th AGM along with the Integrated Annual Report for the financial year 2025-26 is being sent by electronic mode to Members whose e-mail ids are registered with the Company / Registrar & Share Transfer Agent (RTA) / Depository Participants (DPs). In compliance with Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, this letter is being sent to those members whose email ids are not registered with the Company/ RTA/ DP providing the web-link including the exact path to access the Annual Report of Company, which is given below. Website https://smspharma.com/ Exact Path Home Page > Click on “Investors” > Select “Annual Report” Select “Annual Reports 2026” Weblink https://smspharma.com/wp-content/uploads/2026/09/2026.pdf QR Code of Annual Report Kindly note that as per SEBI guidelines, shareholders holding shares in physical form, whose folio(s) do not have PAN, KYC details updated, shall be eligible for dividend in respect of such folios, only through electronic mode. We take this opportunity to reiterate that shareholders, whose folios are not updated with PAN, KYC details, are requested to update the above details by submitting the relevant ISR Forms before the Record date/cut-off date of 22nd September, 2026 to ensure timely credit of dividends. Dividend details: Proposed Dividend Rs. 0.40 per equity share of face value of Rs 1/- each Record date/Cut-off date for eligibility of 22nd September, 2026 Dividend Date for payment of Dividend Within 30 days from the date of declaration of dividend For detailed procedure for remote e-voting Please refer to the 38th AGM Notice of SMS / e-voting and attending AGM through Pharmaceuticals Limited VC/OAVM For any queries or further assistance on KYC updation, demat holders are requested to contact their respective Depository Participants. Holders of physical folios are requested to reach out to the RTA at or at info@aarthiconsultants.com. Thanking you For SMS Pharmaceuticals Limited Thirumalesh Tumma Company Secretary & Compliance Officer